Ratings Anaergia Inc.

Equities

ANRG

CA03253E1079

Market Closed - Toronto S.E. 11:00:00 2024-04-16 am EDT 5-day change 1st Jan Change
0.295 CAD -.--% Intraday chart for Anaergia Inc. -.--% +18.00%

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.
  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • The stock, which is currently worth 2023 to 0.66 times its sales, is clearly overvalued in comparison with peers.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

  • As estimated by analysts, this group is among those businesses with the lowest growth prospects.
  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company has insufficient levels of profitability.
  • The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Environmental Services & Equipment

1st Jan change Capi. Investor Rating ESG Refinitiv
+18.00% 35.46M -
+17.25% 84.43B
C+
+13.60% 59.38B
A-
+17.59% 24.01B -
+26.93% 11.39B
A-
-8.38% 6.14B
B-
+24.36% 4.92B
B+
+14.11% 4.56B
B+
-4.21% 3.07B - -
-2.40% 2.48B
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW